Assignee
RIPPLE THERAPEUTICS CORP
CA·9 granted patents·12 pending applications·16 citations·filing 2019–2024
Top patents by PatentIndex Score
21 records- 0193US10588862B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 17, 2020·5 cites·50 claims
- 0292US10959954B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 30, 2021·3 cites·19 claims
- 0392US10945958B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 16, 2021·3 cites·19 claims
- 0492US10632075B2Glass formulations and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Apr 28, 2020·4 cites·29 claims
- 0585US2025049719A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 0684US11279729B2Heterodimer compositions and methods for the treatment of ocular disordersRIPPLE THERAPEUTICS CORP·Filed 2021·Granted Mar 22, 2022·1 cites·11 claims
- 0781US2023225975A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 0875US11612567B2Ocular inserts comprising a covalently linked steroid dimerRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 28, 2023·0 cites·15 claims
- 0975US2025065053A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 1072US2021205222A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1168US2023113525A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1263US2025074935A1Heterodimer compositions and methods for the treatment of ocular disordersRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 1363US2026007686A1Compositions and methods for improving visionRIPPLE THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 1461US11464914B2Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Oct 11, 2022·0 cites·20 claims
- 1561US2022387213A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 1661US2025057962A1Processable compositions and use for the sameRIPPLE THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1760US2022106351A1Heterodimer compositions and methods for the treatment of ocular disordersRIPPLE THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1855US12473326B2Crystalline forms of dexamethasone dimers and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Nov 18, 2025·0 cites·12 claims
- 1950US12509469B2Compositions and methods for the treatment of pain and dependence disordersRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Dec 30, 2025·0 cites·13 claims
- 2049US2022289787A1Dimer combinations and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 2148US2022288277A1Surface coatings and implantable devices comprising dimeric steroid prodrugs, and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RIPPLE THERAPEUTICS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →